EACR: Nanotechnology 2019
12 - 14 Sep 2019
Churchill College, University of Cambridge, Cambridge, United Kingdom of Great Britain and Northern Ireland
Nanotechnology offers exciting opportunities in the fight against cancer. New technological breakthroughs have enabled innovative therapeutic applications of nanoparticles and have facilitated diagnostics at the nanoscale. As examples, the delivery of RNA with nanoparticles (in the product patisiran), has been approved by EMA/FDA in 2018, while the first liquid biopsy for prostate cancer based on exosome analysis was launched in 2016.
The Nanotechnology in Cancer: Engineering for Oncology conference aims to bridge nanotechnology with clinical and pre-clinical cancer research, and to highlight recent applications in patient care. It will provide an overview of the latest developments in the field of cancer-related nanotechnologies. There will be many opportunities to present work, with lively poster sessions and eight proffered papers selected from submitted abstracts. Eight more high-scoring abstracts will be presented as 3 minute Poster Spotlight talks in the lecture theatre.
No items were found.